Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

LYG-409

Product Specifications

CAS Number

3053857-55-6

Target

E3 Ligase

Applications

Ubiquitin

Molecular Formula

C25H20F3N3O6

Additionnal Information

LYG-409 is a potent, selective, and orally bioavailable degrader of GSPT1, with a DC50 of 7.87 nM. It exhibits strong antiproliferative activity in KG-1 cells with an IC50 of 9.50 nM and demonstrates significant antitumor efficacy in vivo in models of acute myeloid leukemia and prostate cancer.
More Discoveries

Explore Other Products

Browse additional items from our catalog

PARL sgRNA CRISPR Lentivector (Human) (Target 1)
K1595202 1.0 µg DNA

PARL sgRNA CRISPR Lentivector (Human) (Target 1)

Sign In for Pricing
View Details
Recombinant Pseudomonas aeruginosa Monofunctional biosynthetic peptidoglycan transglycosylase (mtgA)
MBS7021914-01 0.02 mg

Recombinant Pseudomonas aeruginosa Monofunctional biosynthetic peptidoglycan transglycosylase (mtgA)

Sign In for Pricing
View Details
Recombinant Pseudomonas aeruginosa Monofunctional biosynthetic peptidoglycan transglycosylase (mtgA)
MBS7021914-02 0.1 mg

Recombinant Pseudomonas aeruginosa Monofunctional biosynthetic peptidoglycan transglycosylase (mtgA)

Sign In for Pricing
View Details
Recombinant Pseudomonas aeruginosa Monofunctional biosynthetic peptidoglycan transglycosylase (mtgA)
MBS7021914-03 5x 0.1 mg

Recombinant Pseudomonas aeruginosa Monofunctional biosynthetic peptidoglycan transglycosylase (mtgA)

Sign In for Pricing
View Details
Lentiviral mouse Spaca9 shRNA (UAS) - Lentiviral mouseSpaca9 shRNA (UAS, GFP) (25)
GTR15130388 1 Vial

Lentiviral mouse Spaca9 shRNA (UAS) - Lentiviral mouseSpaca9 shRNA (UAS, GFP) (25)

Sign In for Pricing
View Details
IL13RA2 (CT19, IL-13R, IL13BP, CD213A2, Interleukin-13 Receptor Subunit alpha-2) (MaxLight 650)
MBS6447182-01 0.1 mL

IL13RA2 (CT19, IL-13R, IL13BP, CD213A2, Interleukin-13 Receptor Subunit alpha-2) (MaxLight 650)

Sign In for Pricing
View Details